Helicobacter pylori Seroprevalence in Rheumatoid Arthritis Patients with Interstitial Lung Disease.

MLA

Oka, Shomi, et al. “Helicobacter Pylori Seroprevalence in Rheumatoid Arthritis Patients with Interstitial Lung Disease.” Biomarker Insights, vol. 19, Dec. 2024, p. 11772719241297172. EBSCOhost, https://doi.org/10.1177/11772719241297171.

APA

Oka, S., Higuchi, T., Furukawa, H., Shimada, K., Okamoto, A., Fujimori, M., Hashimoto, A., Komiya, A., Saisho, K., Yoshikawa, N., Katayama, M., Matsui, T., Fukui, N., Migita, K., & Tohma, S. (2024). Helicobacter pylori Seroprevalence in Rheumatoid Arthritis Patients with Interstitial Lung Disease. Biomarker Insights, 19, 11772719241297172. https://doi.org/10.1177/11772719241297171

Chicago

Oka, Shomi, Takashi Higuchi, Hiroshi Furukawa, Kota Shimada, Akira Okamoto, Misuzu Fujimori, Atsushi Hashimoto, et al. 2024. “Helicobacter Pylori Seroprevalence in Rheumatoid Arthritis Patients with Interstitial Lung Disease.” Biomarker Insights 19 (December): 11772719241297172. doi:10.1177/11772719241297171.